It should be of note that zoledronic acid also binds to additional sites in cancers, and it is a well-known potent inhibitor of human farnesyl pyrophosphate synthase, a key enzyme in the mevalonate pathway with apoptotic cell death. The gene discussed is FDPS; the disease is cancer.